60 million J&J vaccine doses need to be thrown out after factory mishap, FDA reportedly says


About 60 million doses of Johnson & Johnson's COVID-19 vaccine that were produced at a troubled factory in Baltimore will have to be thrown out, the FDA has reportedly concluded.
The Food and Drug Administration has decided that these tens of millions of vaccine doses that were produced at a factory operated by Emergent BioSolutions must be thrown out due to possible contamination, The New York Times reports. The FDA will, however, reportedly allow 10 million vaccine doses to still be distributed with warning labels noting that regulators can't guarantee that Emergent "followed good manufacturing practices," the Times reports.
It was reported in March that vaccine doses had been spoiled at a Baltimore plant after workers mistakenly mixed up ingredients. Production at the plant was subsequently paused, and the FDA had been reviewing the situation for weeks. Inspectors who were sent in reported "unsanitary conditions, poorly trained employees and other problems" at the factory, The Associated Press reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Johnson & Johnson COVID-19 vaccine comes with the benefit of only requiring one dose, and while the Times notes that the U.S. has sufficient supply of the Pfizer and Moderna two-dose vaccines, 60 million Johnson & Johnson doses being unusable "puts a dent in the Biden administration's plan to distribute vaccines to other countries that are still in the grip of the pandemic."
A decision about whether the company can reopen the plant reportedly isn't expected to be made until later in the month.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
Why is a new Air Force One taking so long to build?
The Explainer Trump may look for alternatives for his new plane
By Joel Mathis, The Week US Published
-
New and notable podcasts for March
Feature The MeidasTouch Podcast and The Magnificent Others With Billy Corgan
By The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published